...
首页> 外文期刊>International journal of infectious diseases : >Seronegative neurobrucellosis—do we need new neurobrucellosis criteria?
【24h】

Seronegative neurobrucellosis—do we need new neurobrucellosis criteria?

机译:血清腺神经抑制 - 我们需要新的神经抑制标准吗?

获取原文
           

摘要

Neurobrucellosis presents in various clinical forms and should always be considered in neurological patients in highly endemic areas such as the Mediterranean basin. Establishing a diagnosis can be challenging since serological testing can sometimes yield negative results. We present a rare case of a seronegative relapse of neurobrucellosis in a patient who had been successfully treated for systemic brucellosis. Oligoclonal bands, an agglutination test, and 16S rRNA sequencing of cerebrospinal fluid proved essential in unmasking a confined central nervous system relapse. This case reinforces the need for establishing diagnostic criteria for neurobrucellosis, which could potentially include oligoclonal bands and an agglutination test on the cerebrospinal fluid.
机译:神经抑菌性患有各种临床形式,并应始终在诸如地中海盆地等高度流行区域的神经系统患者中考虑。 由于血清学检测有时会产生负面结果,建立诊断可能是挑战性的。 我们在已成功治疗全身安全性的患者中展示了罕见的神经细胞症的血清腺拷贝。 在揭开局限性的中枢神经系统复发中,脑脊液的寡粘接带,凝集试验和16S rRNA测序证明是必不可少的。 这种情况强化了建立神经抑制性诊断标准的需求,这可能包括脑脊髓液上的寡胶带和凝集试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号